Development of a Mass Antiviral Screening System Using Viral Hemorrhagic Septicemia Virus as an RNA Surrogate and Activity Confirmation with a Fish Rhabdovirus
Open Access
Abstract
With emerging viruses and drug resistance on the rise, the discovery and development of innovative antiviral substances and agents are necessary for the effective treatment and control of viral outbreaks. Surrogate viruses are safer alternatives used in research to mimic dangerous or hard-to-culture viruses. They enable efficient, ethical, and cost-effective screening of antiviral compounds. In this study, we used a recombinant viral hemorrhagic septicemia virus (rVHSV) expressing enhanced green fluorescent protein as a surrogate for RNA viruses for the high-throughput screening of antiviral agents. An optimized mixture of viruses and EPC host cells was distributed in 96-well plates containing chemical compounds or plant extracts for screening. Using this system, 44,642 chemical compounds and 8104 plant and marine organism extracts were tested; 140 candidates were selected from primary screening, and 8 compounds and 5 plant extracts were further selected based on the selectivity index (SI), representing the ratio of the cytotoxic concentration (CC50) to the inhibition concentration (IC50). Among these, compound 3, which had the highest SI value of 1046, was further tested, considering in vitro activity against VHSV and another fish rhabdovirus, snakehead rhabdovirus (SHRV).Keywords
Funding Information
- Ministry of Oceans and Fisheries, South Korea (RS-2021-KS211475)
This publication has 72 references indexed in Scilit:
- Paving new roads toward the advancement of broad‐spectrum antiviral agentsJournal of Medical Virology, 2024
- Surrogate model to screen for inactivation‐based clearance of enveloped viruses during biotherapeutics process developmentBiotechnology Journal, 2021
- Heterocyclic compounds as antiviral drugs: Synthesis, structure–activity relationship and traditional applicationsJournal of Heterocyclic Chemistry, 2021
- Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro)Molecular Biotechnology, 2021
- An antiviral drug screening system for enterovirus 71 based on an improved plaque assay: A potential high‐throughput methodJournal of Medical Virology, 2019
- Antiviral effects of extracts from Celosia cristata and Raphanus sativus roots against viral hemorrhagic septicemia virusArchives of Virology, 2017
- Cutthroat trout virus as a surrogate in vitro infection model for testing inhibitors of hepatitis E virus replicationAntiviral Research, 2013
- Antiviral activities of flavonoids isolated from the bark of Rhus verniciflua stokes against fish pathogenic viruses In VitroJournal of Microbiology, 2012
- Guidelines for accurate EC50/IC50 estimationPharmaceutical Statistics, 2011
- The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV)Antiviral Research, 2005